西部中医药
西部中醫藥
서부중의약
Western Journal of Traditional Chinese Medicine
2015年
8期
75-76,77
,共3页
陶玲%杜涛%缪金龙%张玉杰
陶玲%杜濤%繆金龍%張玉傑
도령%두도%무금룡%장옥걸
心力衰竭%心肌病,缺血性%芪苈强心胶囊%N 末端脑利钠肽前体
心力衰竭%心肌病,缺血性%芪藶彊心膠囊%N 末耑腦利鈉肽前體
심력쇠갈%심기병,결혈성%기력강심효낭%N 말단뇌리납태전체
heart failure%cardiomyopathy,ischemic%QiLi QiangXin capsules%NT-proBNP
目的:观察芪苈强心胶囊对老年缺血性心肌病伴心力衰竭患者心功能及血浆 NT-proBNP 水平的影响。方法:将60例老年缺血性心肌病伴心力衰竭患者分为2组,对照组30例给予常规治疗,治疗组30例在此基础上给予芪苈强心胶囊治疗。结果:治疗组显效15例,有效10例,无效5例,总有效率83.3%;对照组显效13例,有效9例,无效8例,总有效率73.33%。2组比较差异具有统计学意义(P<0.05)。治疗后 LVDD 下降、LVEF上升治疗组较对照组更明显(P<0.05)。血浆 NT-proBNP 治疗后2组均明显下降(P<0.05),观察组下降更明显(P<0.05)。结论:芪苈强心胶囊联合传统药物治疗老年缺血性心肌病伴心力衰竭,可有效改善患者的心功能及临床症状。
目的:觀察芪藶彊心膠囊對老年缺血性心肌病伴心力衰竭患者心功能及血漿 NT-proBNP 水平的影響。方法:將60例老年缺血性心肌病伴心力衰竭患者分為2組,對照組30例給予常規治療,治療組30例在此基礎上給予芪藶彊心膠囊治療。結果:治療組顯效15例,有效10例,無效5例,總有效率83.3%;對照組顯效13例,有效9例,無效8例,總有效率73.33%。2組比較差異具有統計學意義(P<0.05)。治療後 LVDD 下降、LVEF上升治療組較對照組更明顯(P<0.05)。血漿 NT-proBNP 治療後2組均明顯下降(P<0.05),觀察組下降更明顯(P<0.05)。結論:芪藶彊心膠囊聯閤傳統藥物治療老年缺血性心肌病伴心力衰竭,可有效改善患者的心功能及臨床癥狀。
목적:관찰기력강심효낭대노년결혈성심기병반심력쇠갈환자심공능급혈장 NT-proBNP 수평적영향。방법:장60례노년결혈성심기병반심력쇠갈환자분위2조,대조조30례급여상규치료,치료조30례재차기출상급여기력강심효낭치료。결과:치료조현효15례,유효10례,무효5례,총유효솔83.3%;대조조현효13례,유효9례,무효8례,총유효솔73.33%。2조비교차이구유통계학의의(P<0.05)。치료후 LVDD 하강、LVEF상승치료조교대조조경명현(P<0.05)。혈장 NT-proBNP 치료후2조균명현하강(P<0.05),관찰조하강경명현(P<0.05)。결론:기력강심효낭연합전통약물치료노년결혈성심기병반심력쇠갈,가유효개선환자적심공능급림상증상。
Objective: To survey the influence of QiLi QiangXin capsules on the levels of NT-proBNP in the plasma and heart function of the patients suffering from senile ischemic cardiomyopathy complicated with heart fail-ure. Methods: Sixty patients were randomized into two group, the control group accepted routine treatment and the treatment group QiLi QiangXin capsules on the basis of routine treatment. Results: There were 15 cases markedly ef-fective, ten cases effective, five cases ineffective and total effective rates of the treatment group was 83.3%; while 13 cases markedly effective, nine cases effective, eight cases ineffective, total effective rate of the control group 70.0%,the differences demonstrated statistical meaning (P<0.05). After treating, the treatment group was more notable than the control group in LVDD decrease and LVEF increase (P<0.05). The levels of NT-proBNP in the plasma in both groups decreased remarkably after treating (P<0.05), the decrease of the observation group was more evident (P<0. 05). Conclusion: QiLi QiangXin capsules jointed with traditional medicine in treating senile ischemic cardiomyopathy complicated with heart failure could effectively improve heart function and clinical symptoms of the patients.